Related Experiment Video
Updated: Sep 13, 2025

Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes
Published on: January 10, 2022
One risk assessment for genetically modified plants
Muffy Koch1, Jaylee DeMond1, Matthew G Pence1
1Simplot Plant Sciences, J. R. Simplot Company, Boise, ID, United States.
Abstract:
With over 30 years' experience conducting risk assessments for genetically modified (GM) plants, regulatory agencies that review the safety of GM plants understand the potential food, feed, and environmental risks associated with these products. This vast regulatory experience is underutilized when risk assessments for GM plants are repeated on a per-country basis. The redundancy in country-by-country reviews of the same GM plants places a disproportionate regulatory burden on developers and strains limited government resources for conducting safety reviews. Requiring repeated, multi-country risk assessments to obtain food and feed import permits or cultivation permits for GM plants is unnecessary as repeated assessments do not change the safety and associated risks of already approved products. To avoid redundancies in the regulation of GM plants, we propose adoption of one, global risk assessment for food, feed, and environmental release carried out to international standards. Our proposed model for one global risk assessment encourages the sharing of food, feed and environmental risk assessment summaries between countries while maintaining national approvals for GM plants. Steps towards a streamlined and efficient review process for GM plants are discussed, including implementing a global, forward-looking approval process that eliminates repetitive risk assessments and re-reviews of low-risk traits. Harmonization of risk assessment is an achievable goal that would accelerate regulatory approvals and enable broader access to the benefits of GM plants which are currently only available to some countries.
Related Concept Videos
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
What is Genetic Engineering?
Plant Breeding and Biotechnology
Mutagenicity and Carcinogenicity
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
CRISPR

